Twelve Prolific Physicists: Likely 1990 Nobel Contenders

What will this year's winner of the Nobel Prize in physics be doing when the Swedish Academy of Sciences makes its decision in October? When the call comes from Stockholm (winners from the United States usually are notified in the early hours of the morning), will the laureate be sound asleep, dreaming about superstrings or superconductivity? Or will he or she be wide awake, pondering the next equation, the newest experiment? When Alfred Nobel wrote his will in November 1895, he established wh

Written byAngela Martello
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

What will this year's winner of the Nobel Prize in physics be doing when the Swedish Academy of Sciences makes its decision in October? When the call comes from Stockholm (winners from the United States usually are notified in the early hours of the morning), will the laureate be sound asleep, dreaming about superstrings or superconductivity? Or will he or she be wide awake, pondering the next equation, the newest experiment?

When Alfred Nobel wrote his will in November 1895, he established what many consider to be the most prestigious of all awards. Yet actual guidelines set down in the will for the Nobel Prize are, for the most part, sparse. The prizes were to go "to those who, during the preceding year, shall have conferred the greatest benefit on mankind." For the field of physics, in particular, Nobel directed that the award go to the person "who shall have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies